CORRECTION article

Front. Pharmacol., 18 September 2019

Sec. Gastrointestinal and Hepatic Pharmacology

Volume 10 - 2019 | https://doi.org/10.3389/fphar.2019.01036

Corrigendum: Dioscin Inhibits HSC-T6 Cell Migration via Adjusting SDC-4 Expression: Insights From iTRAQ-Based Quantitative Proteomics

  • College of Pharmacy, Dalian Medical University, Dalian, China

In the original article, there was a mistake in Figure 6A as published. The authors inserted the wrong image in this figure part. In this corrigendum, we have furthermore provided the correct result of the shRNA+ dio 5.0 μg/mL group, which showed no influence on the results. The corrected Figure 6 appears below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Figure 6

Summary

Keywords

cell migration, dioscin, hepatic stellate cells, iTRAQ, liver fibrosis, syndecan-4

Citation

Yin L, Qi Y, Xu Y, Xu L, Han X, Tao X, Song S and Peng J (2019) Corrigendum: Dioscin Inhibits HSC-T6 Cell Migration via Adjusting SDC-4 Expression: Insights From iTRAQ-Based Quantitative Proteomics. Front. Pharmacol. 10:1036. doi: 10.3389/fphar.2019.01036

Received

08 August 2019

Accepted

14 August 2019

Published

18 September 2019

Volume

10 - 2019

Edited and reviewed by

Ruixin Zhu, Tongji University, China

Updates

Copyright

*Correspondence: Jinyong Peng,

This article was submitted to Gastrointestinal and Hepatic Pharmacology, a section of the journal Frontiers in Pharmacology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics